Neuropathic Peripheral PainNCT06925256
Considering Peripheral Nerve Injury, Is It Safe to Perform Transradial Angiography?
A study testing nerve conduction study in people with Neuropathic Peripheral Pain, run by Bursa City Hospital.
Trial summary
So far, apart from a limited number of case reports and small-scale studies, the frequency and severity of this complication have not been objectively evaluated using electromyography (EMG). Read more about this study
- Who is it for?
- Ages 20 to 60 years
- Conditions the study is for
- Neuropathic Peripheral Pain
- What is being tested?
- nerve conduction study
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- No sites listed yet
- Study dates
- 1 Apr 2026to 30 Apr 2027
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 60 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- 20-60 years old patiens who applied trans angiograhy were included to study
Who cannot join
- Having cognitive disorders
- Patients who have story of cardiac pace / ICD,
- History of polyneuropathy,
- Previous nerve damages,
- Deformities on arm,
- Plexopathy,
Show all 10Show fewer
- Radiculopathy,
- Spinal surgery.
- Having medical treatment for any kind of neuropathy
- Having Cognitive disorders
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: Considerin Peripheral Nerve Injury, Is It Safe to Perform Transradial Angiography?
So far, apart from a limited number of case reports and small-scale studies, the frequency and severity of this complication have not been objectively evaluated using electromyography (EMG). In this study, presence, severity, and extent of nerve injury (one of the potential complications following the transradial approach (TRA)) were evaluated by EMG studies in patients managed at Bursa City Hospital.
Read the detailed description
Evaluation of peripheral nerve injury after transradial angiography with nerve conduction studies.
- Conditions
- Neuropathic Peripheral Pain
- Being tested
- nerve conduction study
- Keywords
- Nerve Conduction Studies, Nerve damage, Transradial angiography
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
nerve conduction studyDiagnostic test
median ulnar and radial motor- sensory nerve conduction studies will be performed.
| Study group | Role | What they receive |
|---|---|---|
| Patients with transradial angiography | Experimental | all patients involved evaluated with NCS Receives: Diagnostic Test: nerve conduction study |
What is being measured
The primary outcome is the main question the study is designed to answer.
Nerve conduction studies (NCS)
NCS (Nerve conduction study) findings obtained after radial intervention A NCS test measures how fast an electrical impulse moves through your nerve. NCS can identify nerve damage. During the test, your nerve is stimulated, often with electrode patches put on your skin. Two electrodes are placed on the skin over your nerve or over a muscle. One electrode stimulates your nerve with a very mild electrical impulse. The other electrode records it. The resulting electrical activity is recorded by another electrode. This is repeated for each nerve being tested. After test below values are obtained;
- Velocity (meter/second),
- Action potential amplitude (miliVolt)
- Onset latans (milisecond)
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Apr 2025
- Study start1 Apr 2026 (estimated)
- Primary completion1 Apr 2027 (estimated)
- Study completion30 Apr 2027 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Neuropathic Peripheral PainStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Bursa City Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Taner Dandinoğlu, Bursa City Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06925256
- Sponsor's protocol ID
- 2025-PMR-1
- Status last verified
- Feb 2026
- First submitted
- 25 Mar 2025
- Last updated
- 4 Feb 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: upon reasonable request will be provided by the authors
Study at a glance
From the registry record, last updated by the sponsor on 4 Feb 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Considerin Peripheral Nerve Injury, Is It Safe to Perform Transradial Angiography?
- ClinicalTrials.gov ID
- NCT06925256
- Acronym / sponsor ID
- 2025-PMR-1
- Conditions
- Neuropathic Peripheral Pain
- Keywords
- Nerve Conduction Studies, Nerve damage, Transradial angiography
- Study type
- Interventional
- Recruitment status
- Not yet recruiting
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Bursa City HospitalOther government
- Study start
- 1 Apr 2026 (estimated)
- Primary completion
- 1 Apr 2027 (estimated)
- Study completion
- 30 Apr 2027 (estimated)
- First posted
- 13 Apr 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
So far, apart from a limited number of case reports and small-scale studies, the frequency and severity of this complication have not been objectively evaluated using electromyography (EMG). In this study, presence, severity, and extent of nerve injury (one of the potential complications following the transradial approach (TRA)) were evaluated by EMG studies in patients managed at Bursa City Hospital.
Detailed description
Evaluation of peripheral nerve injury after transradial angiography with nerve conduction studies.
Study design
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Patients with transradial angiography | Experimental | Diagnostic Test: nerve conduction studyall patients involved evaluated with NCS |
Who may qualify
- Ages
- 20 to 60 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (1 listed)
- 20-60 years old patiens who applied trans angiograhy were included to study
Key exclusion criteria (10 listed)
- Having cognitive disorders
- Patients who have story of cardiac pace / ICD,
- History of polyneuropathy,
- Previous nerve damages,
- Deformities on arm,
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| nerve conduction studymedian ulnar and radial motor- sensory nerve conduction studies will be performed. | Diagnostic test | Patients with transradial angiography |
Primary outcome
Nerve conduction studies (NCS)
Time frame: 1 day
NCS (Nerve conduction study) findings obtained after radial intervention A NCS test measures how fast an electrical impulse moves through your nerve. NCS can identify nerve damage. During the test, your nerve is stimulated, often with electrode patches put on your skin. Two electrodes are placed on the skin over your nerve or over a muscle. One electrode stimulates your nerve with a very mild electrical impulse. The other electrode records it. The resulting electrical activity is recorded by another electrode. This is repeated for each nerve being tested. After test below values are obtained; * Velocity (meter/second), * Action potential amplitude (miliVolt) * Onset latans (milisecond)
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Feb 2026.
- Individual participant dataSharing planned: Yes. upon reasonable request will be provided by the authors
Related trials for Neuropathic Peripheral Pain
RecruitingObservational study
Pain Phenotypes in Individuals With Multiple Sclerosis
Multiple Sclerosis, Chronic Pain
RecruitingPhase 2
A Chronic Pain Master Protocol (CPMP): A Study of LY4065967 in Participants With Diabetic Peripheral Neuropathic Pain
Diabetic Peripheral Neuropathic Pain
Active, not recruiting
Comparative Effects of tDCS and tACS on Pain, Dexterity, and Strength in Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathy (DPN)
Recruiting
Virtual Reality-Based Hypnotherapy for Pain, Sleep, and Mood in Spinal Cord Injury
Spinal Cord Injuries (SCI), Chronic Pain
Not yet recruitingPhase 1
Simultaneous Engagement of Networks for Alleviating Pain (SENAP)
Neuropathic Pain, Postherpetic Neuralgia
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
A study testing nerve conduction study in people with Neuropathic Peripheral Pain, run by Bursa City Hospital.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 4 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Taner Dandinoglu, MD. (90 533 691 4066, dandinoglu@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Nerve conduction studies (NCS) (time frame: 1 day). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2026.